TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ?:TargetMol Chemicals Inc.

??:-

???:marketing@targetmol.com

??:China

? ?? ?:19704

112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198

?? ????

Kallikrein-IN-2	2702983-84-2	C28H25F3N4O4
mGAT-IN-1	2556833-08-8	C28H34ClN3O2S2
Anti-Trypanosoma cruzi agent-3	2397639-23-3	C29H29N3O6S
AChE-IN-12	2764664-52-8	C33H41NO7
Thi-DPPY	2307699-34-7	C28H28ClN5O4S
BuChE-IN-2	2745118-93-6	C28H20F4N6O3
Lipid-lowering agent-1	2304859-34-3	C26H19ClF3NO6S
IZTZ-1	2636771-45-2	C32H35N7S
GLP-1R agonist 8	2736446-82-3	C33H32N4O5
HBV-IN-8	2724224-57-9	C21H25ClFN5O5S2
LXRβ agonist-3	2413308-63-9	C30H33N3O6S
DCN1-UBC12-IN-2	2374827-47-9	C23H20ClN7O3S2
SARS-CoV-2-IN-19	2244991-17-9	C33H38N2O6
PI3K-IN-27	2742654-38-0	C30H26F2N6O2S
Antibacterial agent 115	2259732-60-8	C35H48N2O3
Axl-IN-8	2231424-62-5	C31H29FN6O3
EGFR-IN-31	2701563-03-1	C32H36FN7O2
WNY1613	2650546-39-5	C29H35N9O3
HBV-IN-19 TFA	2241575-60-8
DNMT3A-IN-1	1403598-56-0	C30H38N6O4
RAD51-IN-6	2690367-57-6	C27H40N3O5PS
PG 34	1681056-62-1	C28H25N3O5S2
Antitubercular agent-19	2248171-05-1	C24H20F6N4O3S
Estrogen receptor antagonist 3	2730011-50-2	C26H29BF6N4O2
PDE5/HDAC-IN-1	2414921-48-3	C27H29BrN4O4
Anticancer agent 61	2413148-53-3	C22H22N3Na2O8PS
RET-IN-17	1885880-08-9	C27H28F4N4O4
PLK1-IN-4	2622273-55-4	C24H25F3N6O4S
Sitagliptin fenilalanil	1339955-03-1	C25H24F6N6O2
B-Raf IN 6	2648698-34-2	C24H21F3N6O2S2
hCAXII-IN-3	2417232-24-5	C26H20BrN5O3S
CYP3A4-IN-3	2562384-19-2	C34H39N3O3S
Anticancer agent 67	2691895-66-4	C26H24F2N6O2S2
Lp-PLA2-IN-9	2637485-12-0	C25H19ClF5N3O4
ACC1/2-IN-1	2350219-22-4	C34H32N4O4
CYP3A4-IN-2	2562383-94-0	C33H38N4O3S
Cap-dependent endonuclease-IN-14	2740486-73-9	C30H23FN2O6S
α-Glycosidase-IN-1	2428389-66-4	C21H19N9O6S2
MAT2A-IN-1	2667053-18-9	C29H28F2N6O4
DPP-4/GPR119 modulator 2	2010927-65-6	C30H40N8O3
RECQL5-IN-1	2718170-45-5	C25H18F6N4O2S
LRRK2-IN-2	2641059-19-8	C23H23Cl2F3N6O2
Axl-IN-5	2642224-24-4	C31H35N5O2S
HIV-1 protease-IN-2	2248124-46-9	C27H34N4O7S
ERα antagonist 1	2762423-09-4	C33H32N2O5S
PAK4-IN-1	2396529-58-9	C26H30ClN7O5
ALK5-IN-9	2489611-06-3	C29H35F3N6O3
BCR-ABL-IN-4	2669790-59-2	C27H24ClF2N5O4
CDK9/10/GSK3β-IN-1	2423045-06-9	C29H24ClN3O4S
RORγt agonist 3	2664106-24-3	C34H37N3O3S
SAP2-IN-1	2512847-37-7	C34H29NO7
Adenylyl cyclase type 2 agonist-1	2414908-52-2	C27H17BrClNO5
RET-IN-19	2484919-71-1	C28H28N6O4S
CYP3A4-IN-1	2771297-34-6	C31H37N5O3S
CCT373567	2378853-67-7	C26H29ClF2N6O3
Multi-kinase-IN-3	2091950-43-3	C33H33N5O3
IRE1α kinase-IN-3	2416223-41-9	C29H32N6O3S
EZH2-IN-11	2387402-80-2	C28H36ClN3O5S
DHODH-IN-22	2450341-75-8	C21H21ClF4N6O5
BLK-IN-1	1431727-00-2	C29H23F3N6O3
Tubulin polymerization-IN-7	1394017-46-9	C28H24N4O6S
EGFR-IN-50	2044508-48-5	C24H26BrN3O4S2
ATR-IN-5	2601571-19-9	C27H32F3N9O
KS100	2408477-54-1	C17H14Br3N3O2S
Omesdafexor	2244440-85-3	C34H43N3O3
XP-524	2344825-52-9	C30H28N6O3S
PRMT5-IN-18	2756849-68-8	C32H42N4O4
GLP-1R agonist 10	2762515-25-1	C29H29ClFN5O4
HER2-IN-8	2704630-49-7	C26H25F2N9O3
HDAC-IN-44	2414921-46-1	C26H27BrN4O4
Anticancer agent 76	2448091-11-8	C32H33NO5S
MMP-9-IN-4	2581824-39-5	C28H19F3N4O6
HIV-IN-5	2459929-62-3	C30H24N2O8S
Antitubercular agent-20	2413124-92-0	C25H22F6N4O3S
c-Met-IN-13	2377724-93-9	C30H28F2N2O6
HBV-IN-6	2724224-47-7	C23H21ClFN3O5S2
LDC0496	2411874-83-2	C32H35N5O3
IKKβ-IN-1	2410423-31-1	C31H30N4O4S
HER2-IN-7	2387574-01-6	C28H26F3N7O3
Cap-dependent endonuclease-IN-5	2416258-53-0	C27H21F2N3O4S2
VEGFR-2-IN-28	2447597-39-7	C26H17N7O7
AChE-IN-20	2428389-65-3	C22H20N8O6S2
VEGFR-2-IN-22	2447587-73-5	C26H24ClFN4O6
Axl-IN-12	2758062-17-6	C30H30N8O3
Antitumor agent-45	2581082-74-6	C28H17BrFN5O3
Antimycobacterial agent-3	2469881-50-1	C21H15F6N5O4S
Cap-dependent endonuclease-IN-17	2649362-71-8	C24H20F2N3O7PS
HDAC-IN-36	2482992-54-9	C29H39N5O5
Keap1-Nrf2-IN-14	1928782-31-3	C30H29NO8S
A3AR antagonist 1	2413257-74-4	C32H24N4O4S
Anticancer agent 41	1394077-28-1	C25H18Br2N2O3
RAD51-IN-5	2690367-19-0	C26H38N4O5S2
Multi-kinase-IN-2	2095628-21-8	C34H35N5O3
EGFR-IN-32	2701553-78-6	C31H34N6O3
BACE1-IN-12	2479315-19-8	C29H28Cl2N6O
c-Fms-IN-12	2145102-33-4	C30H32N6O6
hGGPPS-IN-2	2241547-82-8	C20H18FN5O7P2S
RORγt inverse agonist 28	2741870-21-1	C23H18Cl2F3NO5S
hCA I-IN-2	2417232-12-1	C26H20BrN5O3S
Anticancer agent 50	2487457-15-6	C30H32N2O4Se

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ????